655000L060216 |enzyme nscriptase
Ended Awarded
- Contract number
- HHSN263NDX04831
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,246
Award facts
- Contract value
-
- $4,245.90 Current, with exercised options
- $0.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Not on record Potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 0 offers Simplified Acquisition
- Pricing
- Other
- Place of performance
- MONTGOMRY VLG, MD 20877, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSN263NDX04831?
HHSN263NDX04831 was awarded to Roche Diagnostics Corporation by Office of the Director (National Institutes of Health) on April 17, 2006.
How much is contract HHSN263NDX04831 worth?
The government has obligated $4,246 on HHSN263NDX04831.
Is contract HHSN263NDX04831 an order under another contract?
Yes. HHSN263NDX04831 is a BPA call under GS24F1283C-HHSN263199900051732B, a blanket purchase agreement.
Was contract HHSN263NDX04831 competed?
The government received 0 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award